Protect Healthcare from Tariffs
PROTECT Healthcare from Tariffs
Tariffs on medical products mean higher costs for providers, which could postpone procedures or even cancel surgeries for patients. The Radiology Patient Action Network (RPAN, an organization of radiology specialists and advocates), is asking Congress to exempt medical products from tariffs. If tariffs are imposed, we propose a three-year delay for implementation to allow manufacturers time to adjust, and a streamlined process for companies to apply for tariff exclusions on critical medical devices to prevent shortages and maintain patient care quality.
Sign below to ask your Representative in Congress to support these actions to protect access to healthcare across the country:
Contact Us
We will get back to you as soon as possible.
Please try again later.
Dear (Your Representative Here),
I urge you to support an exemption for medical technology (medtech) products from the Trump-era and proposed Section 301 tariffs.
Medical devices—ranging from imaging tools to surgical kits and essential supplies—are vital to U.S. healthcare providers and patients. Many of these products rely on global supply chains, particularly partnerships with trusted allies to meet growing demand. Tariffs on these items disrupt access, increase the cost of care, and jeopardize both innovation and patient
Providers cannot simply pass along tariff costs. These increased costs hurt U.S. manufacturers, reduce investment in innovation, and force painful provider decisions about care access and staffing.
We respectfully ask Congress to:
- Support a full exemption of medical technology products from any Section 301 tariffs.
- Urge the Administration to establish a clear, time-limited product exclusion process for critical devices.
- Delay implementation of any medtech tariffs for at least 3 years, allowing time for regulatory and supply chain adjustments.
Patients’ lives depend on timely access to safe, effective, and affordable technology. Please help protect that access by supporting a medtech tariff exemption.
Sincerely,
(Your Name Here)
GET THE FACTS:
What’s the problem?
Tariffs on medical technology products could increase costs for providers and patients. Many medtech products rely on complex international supply chains, and imposing tariffs would disrupt those chains, increase expenses, and reduce access to essential medical equipment. Contrast costs have already doubled since 2019.
How does it impact you?
Higher costs for providers may lead to reduced access to medical devices, postponed procedures, or even canceled surgeries. Products like contrast and other essential diagnostic tools would become much more expensive or harder to obtain. This would particularly harm vulnerable populations, including the elderly and children.
What is the solution?
RPAN is advocating for medical technology products to be exempt from tariffs. If tariffs are imposed, they propose a three-year delay for implementation to allow manufacturers time to adjust. Additionally, they recommend a streamlined process for companies to apply for tariff exclusions on critical medical devices to prevent shortages and maintain patient care quality.